Immunohistological analysis of immune cells in blistering skin lesions

Journal of Clinical Pathology

Volumn 60, Issue 1, 2007, Pages 62-71

  Hussein, Mahmoud R ^a   Ali, Fayed Mahammad Nagy ^a   Omar, Abd Elhady M M ^a  

^a Assiut University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; GRANZYME B;

ADULT; ARTICLE; B LYMPHOCYTE; BLISTER; BULLOUS SKIN DISEASE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; FEMALE; HISTIOCYTE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOPEROXIDASE STAINING; INFLAMMATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; CHILD; CHILD, PRESCHOOL; EPIDERMIS; FEMALE; HISTIOCYTES; HUMANS; IMMUNITY, CELLULAR; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; NEUTROPHILS; SKIN DISEASES, VESICULOBULLOUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33846412194     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.037010     Document Type: Article

References (54)

1. Benbow M. Bullous skin disorders. Nurs Times 1996;92:66-8.
2. Barnadas MA, Gelpi C, Curell R, et al. Repeat direct immunofluorescence test, using, 1 M NaCl treated skin, in the subepidermal autoimmune bullous diseases that contain IgG at the dermal epidermal junction. J Cutan Pathol 1999;26:37-41.
3. Barnadas MA, Gonzalez MJ, Planaguma M, et al. Clinical, histopathologic, and therapeutic aspects of subepidermal autoimmune bullous diseases with IgG on the floor of salt-split skin. Int J Dermatol 2001;40:268-72.
4. Schaerli P, Britschgi M, Keller M, et al. Characterization of human T cells that regulate neutrophilic skin inflammation. J Immunol 2004;173:2151-8.
5. Schaller J, Niedecken HW, Biwer E, et al. Characterization of lymphocytic infiltrate cells in bullous pemphigoid and pemphigus vulgaris. Dermatol Monatsshr 1990;176:661-8.
6. Diaz J, Tubbs R, Stoler M, et al. Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. SWOG Central Repository Members. Leuk Lymphoma 1993;9:91-4.
7. Taupin JL, Tian Q, Kedersha N, et al. The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proc Natl Acad Sci USA 1995;92:1629-33.
8. Amsterdam A, Keren-Tal I, Aharoni D, et al. Steroidogenesis and apoptosis in the mammalian ovary. Steroids 2003;68:861-7.
9. Amsterdam A, Sasson R, Keren-Tal I, et al. Alternative pathways of ovarian apoptosis: death for life. Biochem Pharmacol 2003;66:1355-62.
10. Davidorf FH, Lang JR. Lymphocytic infiltration in choroidal melanoma and its prognostic significance. Trans Ophthalmol Soc UK 1977;97:394-401.
11. Saito T, Tanaka R, Kouno M, et al. Immunohistological analysis of infiltrating lymphocyte subpopulations in gliomas and metastatic brain tumors. No To Shinkei 1987;39:339-45.
12. Hussein MR. Dendritic cells and melanoma tumorigenesis: an insight. Cancer Biol Ther 2005;4:501-5.
13. Chan WY, Cheung KK, Scharge JO, et al. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol 2000;156:409-17.
14. Hussein MR, Al-Badaiwy ZH, Guirguis MN. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferafive lesions. J Cutan Pathol 2004;31:643-51.
15. Hussein MR, Hassan HI, Hofny ER, et al. Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis. J Clin Pathol 2005;58:178-84.
16. Hussein MR, Al-Sabae TM, Georgis MN. Analysis of the Bcl-2 and p53 protein expression in the lymphoproliferative lesions in the Upper Egypt. Cancer Biol Ther. 2005;12:305-58.
17. Hunyadi J, Szabo I, Simon M Jr. Skin as an immune system. Orv Hetil 1994;135:2749-54.
18. Caproni M, Giomi B, Cardinali C, et al. Further support for a role for Th2-like cytokines in blister formation of pemphigus. Clin Immunol 2001;98:264-71.
19. Frezzolini A, Teofoli P, Cianchini G, et al. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid. Eur J Dermatol 2002;12:27-31.
20. Fabbri P, Caproni M, Berti S, et al. The role of T lymphocytes and cytokines in the pathogenesis of pemphigoid gestationis. Br J Dermatol 2003;148:1141-8.
21. Heiligenhaus A, Schaller J, Mauss S, et al. Eosinophil granule proteins expressed in ocular cicatricial pemphigoid. Br J Ophthalmol 1998;82:312-17.
22. Kuhns DB, DeCarlo E, Hawk DM, et al. Dynamics of the cellular and humoral components of the inflammatory response elicited in skin blisters in humans. J Clin Invest 1992;89:1734-40.
23. Giacalone B, D'Auria L, Ferraro C, et al. Bullous pemphigoid blisters of the same duration have similar cytokine concentrations which decrease in older blisters. Br J Dermatol 1998;139:158-9.
24. Rico MJ, Benning C, Weingart ES, et al. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Br J Dermatol 1999;140:1079-86.
25. Sun CC, Wu J, Wong TT, et al. High levels of interleukin-8, soluble CD4 and soluble CD8 in bullous pemphigoid blister fluid. The relationship between local cytokine production and lesional T-cell activities. Br J Dermatol 2000;143:1235-40.
26. Takemiya M, Shiraishi S, Miki Y. A vegetating variety of pemphigus foliaceus. Dermatologica 1990;180:102-5.
27. Hoss DM, Shea CR, Grant-Kels JM. Neutrophilic spongiosis in pemphigus. Arch Dermatol 1996;132:315-18.
28. Feliciani C, Toto P, Mohammad Pour S, et al. A Th2-like cytokine response is involved in bullous pemphigoid. The role of IL-4 and IL-5 in the pathogenesis of the disease. Int J Immunopathol Pharmacol 1999;12:55-61.
29. Pappalardo E, Abramo F, Noli C. Pemphigus foliaceus in a goat. Vet Dermatol 2002;13:331-6.
30. Hashizume H, Iwatsuki K, Takigawa M. Epidermal antigens and complement-binding anti-intercellular antibodies in pemphigus vegetans, Hallopeau type. Br J Dermatol 1993;129:739-43.
31. O'Toole EA, Mak LL, Guitart J, et al. Induction of keratinocyte IL-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol 2000;119:217-24.
32. Hietanen J. Acantholytic cells in pemphigus. A scanning and transmission electron microscopic study. Acta Odontol Scand 1982;40:257-73.
33. Buslau M, Marsch WC. Pemphigus herpetiformis-the value of simple diagnostic measures. Z Hautkr 1989;64:729-30, 35-6.
34. Muramatsu T, Iida T, Honoki K, et al. Pemphigus vulgaris preceded by herpetiform-like skin lesions with negative immunofluorescence findings. J Dermatol 1999;26:154-9.
35. Muramatsu T, Ko T, Honoki K, et al. Intraepidermal expression of basement membrane components in the lesional skin of a patient with dystrophic epidermolysis bullosa. J Dermatol 1999;26:106-10.
36. Lin MS, Mascara JM Jr, Liu Z, et al. The desmosome and hemidesmosome in cutaneous autoimmunity. Clin Exp Immunol 1997;107(Suppl 1):9-15.
37. Talanin NY, Shelley WB, Shelley ED. IgE bullous disease. Clin Exp Dermatol 1997;22:82-6.
38. Veldman CM, Gebhard KL, Uter W, et al. T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. J Immunol 2004;172:3883-92.
39. Zillikens D, Ambach A, Zentner A, et al. Evidence for cell-mediated immune mechanisms in the pathology of pemphigus. Br J Dermatol 1993;128:636-43.
40. Schmidt E, Bastion B, Dummer R, et al. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid. Arch Dermatol Res 1996;288:353-7.
41. Nakamura K, Yasaka N, Asahina A, et al. Increased numbers of CD68 antigen positive dendritic epidermal cells and upregulation of CLA (cutaneous lymphocyte-associated antigen) expression on these cells in various skin diseases. J Dermatol Sci 1998;18:170-80.
42. Nepom GT, Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991;9:493-525.
43. Day MJ. Expression of major histocompatibility complex class II molecules by dermal inflammatory cells, epidermal Langerhans cells and keratinocytes in canine dermatological disease. J Comp Pathol 1996;115:317-26.
44. Miyagawa S, Amagai M, Iida T, et al. Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression. Br J Dermatol 1999;141:1084-7.
45. Hertl M, Veldman C. T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skin. Autoimmun Rev 2003;2:278-83.
46. Loewenthal R, Slomov Y, Gonzalez-Escribano MF, et al. Common ancestral origin of pemphigus vulgaris in Jews and Spaniards: a study using microsatellite markers. Tissue Antigens 2004;63:326-34.
47. D'Auria L, Pimpinelli F, Ferraro C, et al. Relationship between theoretical molecular weight and blister fluid/serum ratio of cytokines and five other molecules evaluated in patients with bullous pemphigoid. J Biol Regul Homeost Agents 1998;12:76-80.
48. Miyagawa S, Amagai M, Niizeki H, et al. HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus. Tissue Antigens 1999;54:333-40.
49. Tenaud I, Leroy S, Chebassier N, et al. Modulation in vitro of keratinocyte integrins by interferon-alpha and interferon-gamma. Int J Dermatol 2002;41:836-40.
50. Budinger L, Borradori L, Yee C, et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998;102:2082-9.
51. Petzelbauer P, Fodinger D, Rappersberger K, et al. CD68 positive epidermal dendritic cells. J Invest Dermatol 1993;101:256-61.
52. Djemadji-Oudjiel N, Goerdt S, Kodelja V, et al. Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis. Arch Dermatol Res 1996;288:757-64.
53. Emile JF, Fraitag S, Leborgne M, et al. Langerhans' cell histiocytosis cells are activated Langerhans cells. J Pathol 1994;174:71-6.
54. Ambach A, Zillikens D, Klingert B, et al. Immune phenotyping of mononuclear infiltrate in bullous pemphigoid. Hautarzt 1992;43:81-5.